Oh Deb, that is awesome news! Keep us updated please!Someone I know, who stays in touch with Dr. Shore, told me today that she is trying to commercialize her device before 2023.
I think they'll have to factor in people's budgets. I wouldn't worry about that.I'm afraid they will be successful but so expensive I won't be able to afford treatment/purchase so I will be no better off.
Commercialization means that we will be able to purchase it. It means developing the production, supply chain, distribution, fitting and sale of the devices. I think this is opposed to its current status as an experimental device that you have to be part of the clinical trial to receive.@DebInAustralia, I wonder if anyone has even a clue what they mean by commercialization? Clinics where we go for treatment? Devices for home use?
I'm afraid they will be successful but so expensive I won't be able to afford treatment/purchase so I will be no better off.
I wouldn't rule it out.I've read in more than one place that the volunteers were all chosen because they have the ability to alter the sound of their tinnitus by putting pressure on their head or clenching their jaws.
So I am assuming the device will only help those with that kind of tinnitus, which is not me. Another Fail.
And even those are probably not going to have much difference on their tinnitus; Lenire failed, why wouldn't this?I am assuming the device will only help those with that kind of tinnitus
You're better off waiting for regeneration medicine like FX-322, PIPE-505 and OTO-413. I really hope PIPE-505 results are positive. That would put it about the same timeline as FX-322 so we could get both.And even those are probably not going to have much difference on their tinnitus; Lenire failed, why wouldn't this?
In Dr. Shore's clinical trials there was great success. Some people actually had their tinnitus go away completely and the others had much quieter tinnitus. They found that the effect was not permanent so I think there's going to be a small device you use at home maybe every day or maybe once a week. This is what I read today in an interview with Dr. Shore.And even those are probably not going to have much difference on their tinnitus; Lenire failed, why wouldn't this?
What kind of tinnitus did those people have? Can you share a link to the interview please?In Dr. Shore's clinical trials there was great success. Some people actually had their tinnitus go away completely and the others had much quieter tinnitus. They found that the effect was not permanent so I think there's going to be a small device you use at home maybe every day or maybe once a week. This is what I read today in an interview with Dr. Shore.
They are able to change their tinnitus sound by applying pressure to their heads or clenching their jaws. This is disconcerting to me as I certainly can't do that! So now I'm wondering if this is going to be helpful!What kind of tinnitus did those people have? Can you share a link to the interview please?
Dr. Shore's device theoretically is a more targeted application.And even those are probably not going to have much difference on their tinnitus; Lenire failed, why wouldn't this?
The sample size of her trials to date was very small, smaller than Neuromod's even. I wouldn't draw any conclusions about it yet. The Minnesota device seemed more promising, TBH, but now that project is dead.In Dr. Shore's clinical trials there was great success.
My tinnitus is from neck and jaw issues. Before I got my TMJ splint, I had about 4-5 different sounds in different locations in my head. Now I only have 1 most of the time, but sometimes 2 sounds. I can never modulate my main sound, but if I yawn, turn my neck, etc I can modulate a second sound...You're better off waiting for regeneration medicine like FX-322, PIPE-505 and OTO-413. I really hope PIPE-505 results are positive. That would put it about the same timeline as FX-322 so we could get both.
These Universities, especially one as big as Minnesota make tons of money. Too bad it got cancelled.The sample size of her trials to date was very small, smaller than Neuromod's even. I wouldn't draw any conclusions about it yet. The Minnesota device seemed more promising, TBH, but now that project is dead.
What does the amount of money the universities make have to do with anything? Most of university research is the faculty being granted external funding by places like the national science foundation and many other funding repositories, and then the university actually *takes*, not gives, funds from the faculty to cover the expenses of their lab (overhead, utilities, janitorial services etc...). I was also under the impression until recently that universities directly funded research, but I have multiple friends who are doing PhDs and are Fullbright scholars, and they all tell me 95% of scientific grants come from funding outside the university itself (in the cases of the people I know - Cornell, Columbia, and Wisconsin-Madison).These Universities, especially one as big as Minnesota make tons of money. Too bad it got cancelled.
I believe Dr. Shore's device does not stimulate the vagus nerve, though someone may correct me. It stimulates the cheek and neck rather than the tongue.After the failure of the FX-322 Phase 2a, my hopes are now focused on Susan Shore's device.
But a question is bothering me; what do you think are the probabilities that this device causes trigeminal neuralgia?
We know that Lenire can cause this terrible disease (one person on this forum contracted this disease only 6 days after using Lenire).
This scares me a lot.
Do you know if Susan Shore's device stimulates the same nerves as Lenire?
The sample size of her trials to date was very small, smaller than Neuromod's even. I wouldn't draw any conclusions about it yet. The Minnesota device seemed more promising, TBH, but now that project is dead.
Susan CPETL Shore . In all seriousness she's doing a lot of good work and I hope it benefits us.Can't predict exact timeline should be the motto of the Shore device.
I guess any research is better than no research.Susan CPETL Shore . In all seriousness she's doing a lot of good work and I hope it benefits us.